Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 1996

Report of the Australian Mycobacterium Reference Laboratory Network

Authors

  • David Dawson WHO Collaborating Centre in Tuberculosis Bacteriology, Queensland Health Pathology Services, Brisbane; The Prince Charles Hospital, Chermside, Queensland 4032

DOI:

https://doi.org/10.33321/cdi.1998.22.42

Keywords:

Mycobacterium tuberculosis complex

Abstract

The Australian Mycobacterium Reference Laboratory Network collected and analysed laboratory data on new diagnoses of infection with Mycobacterium tuberculosis complex during 1996. A total of 750 cases were identified, representing an annual incidence of 4.1 cases of laboratory confirmed tuberculosis per 100,000 population. The incidence rate varied between States, reflecting differences in the distribution of persons belonging to 'high-risk' categories for tuberculosis. Incidence statistics were almost identical to those recorded by the Network in 1994 and 1995. The male:female ratio remained at around 1.2:1. As was the case in 1995, the median age group for males was 45-49 years and for females 35-39 years. The frequency of positive microscopy in pulmonary samples was stable at around 55%. Lymphatic disease accounted for 19% of the total cases in 1996 compared with 15% in the previous year, confirming that lymphadenitis is becoming more common in females with tuberculosis in Australia. Approximately 11% of isolates had in vitro resistance to at least one of the four standard anti-tuberculosis drugs, an increase from 8% in 1994-95. Fifteen isolates were multi-drug resistant, compared with a total of only 38 during the previous seven years. Thus, the 1996 data points to an increasing frequency of multi-drug resistant strains among isolates from Australian patients with tuberculosis. Commun Dis Intell 1998;22:183-187.

Downloads

Download data is not yet available.

References

Raviglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis: Morbidity and mortality of a worldwide epidemic. JAMA 1995;272:220-226.

Oliver G, Harvey B. Tuberculosis notifications in Australia, 1995. Commun Dis Intell 1997;21:261-269.

Tuberculosis Working Party of the National Health and Medical Research Council. Towards Elimination of Tuberculosis II (Final Draft). May 1998.

Dawson D, Anargyros P, Blacklock Z et al. Tuberculosis in Australia: An analysis of cases identified in reference laboratories in 1986-88. Pathology 1991;23:130-134.

Dawson DJ, Cheah DF, Chew WK, Haverkort FC, Lumb R, Sievers AS. Tuberculosis in Australia, 1989-1992: Bacteriologically confirmed cases and drug resistance. Med J Aust 1995;162:287-290.

Curran M, Dawson D. Tuberculosis in Australia: Bacteriologically confirmed cases and drug resistance, 1993. Commun Dis Intell 1995;19:343-345.

Dawson D. Tuberculosis in Australia: Bacteriologically confirmed cases and drug resistance, 1994 and 1995. Commun Dis Intell 1997;21:245-249.

Patel A, Streeton J. Tuberculosis in Australia and New Zealand into the 1990's. 1990. Australian Government Publishing Service, Canberra.

Gilroy N, Oliver G and Harvey B. Tuberculosis notifications in Australia, 1996. Commun Dis Intell 1998;22:173-183.

World Health Organization. TB is the single biggest killer of young women. Global Tuberculosis Programme, Geneva 1998. (Press release)

HIV/AIDS and related diseases in Australia: Annual Surveillance Report 1997. National Centre in HIV Epidemiology and Clinical Research, Sydney.

Cohn DL, Bustreo F, Raviglione MC. Drug resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. Clin Infect Dis 1997;24:S121-30.

Anti-tuberculosis drug resistance in the world. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. WHO/TB/97.229. WHO Global Tuberculosis Prorgamme, Geneva. 1997.

Downloads

Published

03/09/98

How to Cite

Dawson, David. 1998. “ Tuberculosis in Australia: Bacteriologically Confirmed Cases and Drug Resistance, 1996: Report of the Australian Mycobacterium Reference Laboratory Network”. Communicable Diseases Intelligence 22 (September):183-88. https://doi.org/10.33321/cdi.1998.22.42.

Issue

Section

Original article

Categories